WORK Medical Technology Group Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for WORK Medical Technology Group LTD (WOK) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Sep 2023Sep 2022Sep 2021Sep 2020
Operating Activities
Net Income-1.07-3.490.110.875.961.16
Depreciation & Amortization0.921.391.603.264.193.16
Deferred Income Tax0.11-0.05-0.09-0.31-0.120.00
Change in Working Capital6.44-0.110.46-7.13-18.1618.13
Change in Accounts Receivable1.021.82-0.13-3.96-0.12-0.09
Change in Inventory0.571.580.581.866.89-21.66
Change in Accounts Payable0.25-2.550.86-5.82-2.058.75
Change in Other Working Capital4.60-0.95-1.041.461.580.04
Other Operating Activities-0.150.02-0.12-0.350.560.17
Net Cash from Operating Activities6.24-2.232.21-2.26-7.1827.20
Investing Activities
Capital Expenditures-1.33-9.26-0.46-2.01-0.06-17.55
Acquisitions0.390.000.000.060.000.00
Purchases of Investments0.000.000.000.00-0.160.00
Sales/Maturities of Investments0.000.00-0.130.000.000.00
Other Investing Activities-6.660.160.000.000.000.00
Net Cash from Investing Activities-7.61-9.06-0.58-1.35-0.06-16.84
Financing Activities
Debt Repayment-6.171.05-6.00-7.25-9.28-17.66
Common Stock Issued6.907.370.000.000.790.00
Other Financing Activities-1.637.23-3.843.575.750.00
Net Cash from Financing Activities-0.9015.66-0.733.577.99-10.28
Summary
Effect of Forex Changes on Cash-0.610.56-0.03-0.06-0.080.00
Net Change in Cash-2.874.920.86-0.100.75-0.05
Cash at Beginning of Period6.961.640.770.870.200.00
Cash at End of Period4.096.561.640.770.870.00
Free Cash Flow4.91-11.491.75-4.27-7.249.65
Supplemental Disclosures
Interest Paid0.510.540.310.310.310.24
Income Taxes Paid0.010.010.160.340.120.28